Defender Capital, LLC.

SEC CIK: 0001766929
Latest filing: Jul 9, 2026

SEC filings (opens in a new tab)

IMDX holding history

Insight Molecular Diagnostics Inc. in every 13F filed by Defender Capital, LLC., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMDX overview All 13F holders of IMDX Full Q2 2026 holdings

Shares (Q3 2025): 0; Sold out in Q3 2025
Value: $0
% of portfolio: 0.0%
Quarters held: 18; Since Q1 2021

Holdings of IMDX by Defender Capital, LLC., by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q3 2025	0	$0	0.0%	−32,928−100.0%	Sold out	Holders
Q2 2025	32,928	$99.4K	<0.1%	−11,450−25.8%	Reduced	Holders
Q1 2025	44,378	$126.9K	0.1%	−2,700−5.7%	Reduced	Holders
Q4 2024	47,078	$112.0K	<0.1%	−12,275−20.7%	Reduced	Holders
Q3 2024	59,353	$169.2K	0.1%	+4,133+7.5%	Added	Holders
Q2 2024	55,220	$162.9K	0.1%	−665−1.2%	Reduced	Holders
Q1 2024	55,885	$163.7K	0.1%	−15,765−22.0%	Reduced	Holders
Q4 2023	71,650	$179.1K	0.1%	−42,870−37.4%	Reduced	Holders
Q3 2023	114,520	$357.3K	0.1%	−1,877−1.6%	ReducedConverted for a 1-for-20 split	Holders
Q2 2023	2,327,930	$535.1K	0.2%	−35,500−1.5%	Reduced	Holders
Q1 2023	2,363,430	$837.6K	0.3%	+90,500+4.0%	Added	Holders
Q4 2022	2,272,930	$729.4K	0.3%	−279,050−10.9%	Reduced	Holders
Q3 2022	2,551,980	$1.88M	0.7%	−37,400−1.4%	Reduced	Holders
Q2 2022	2,589,380	$2.33M	0.9%	+27,250+1.1%	Added	Holders
Q1 2022	2,562,130	$4.00M	1.4%	+345,330+15.6%	Added	Holders
Q4 2021	2,216,800	$4.81M	1.5%	+255,980+13.1%	Added	Holders
Q3 2021	1,960,820	$6.93M	2.3%	+613,620+45.5%	Added	Holders
Q2 2021	1,347,200	$7.73M	2.6%	+742,750+122.9%	Added	Holders
Q1 2021	604,450	$3.12M	1.1%	–	–	Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.